Overview

A Crossover Pilot Study of the Effect of Amiloride on Proteinuria

Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This cross-over study is designed to test the hypothesis that amiloride will reduce urinary protein excretion and protect the kidney from rapid progression in proteinuric kidney disease.
Phase:
Phase 4
Details
Lead Sponsor:
Georgetown University
Treatments:
Amiloride
Triamterene